JP2011503137A - 新規のアルギニン置換ペプチド及びその使用 - Google Patents

新規のアルギニン置換ペプチド及びその使用 Download PDF

Info

Publication number
JP2011503137A
JP2011503137A JP2010533548A JP2010533548A JP2011503137A JP 2011503137 A JP2011503137 A JP 2011503137A JP 2010533548 A JP2010533548 A JP 2010533548A JP 2010533548 A JP2010533548 A JP 2010533548A JP 2011503137 A JP2011503137 A JP 2011503137A
Authority
JP
Japan
Prior art keywords
cys
ser
ala
arg
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010533548A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503137A5 (enExample
Inventor
マツビー−バルツァー、インガー
ドルフィン、ギュンナー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaSurgics in Sweden AB
Original Assignee
PharmaSurgics in Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaSurgics in Sweden AB filed Critical PharmaSurgics in Sweden AB
Publication of JP2011503137A publication Critical patent/JP2011503137A/ja
Publication of JP2011503137A5 publication Critical patent/JP2011503137A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2010533548A 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用 Pending JP2011503137A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
US99006607P 2007-11-26 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (2)

Publication Number Publication Date
JP2011503137A true JP2011503137A (ja) 2011-01-27
JP2011503137A5 JP2011503137A5 (enExample) 2012-01-05

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533548A Pending JP2011503137A (ja) 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用

Country Status (9)

Country Link
US (2) US7928185B2 (enExample)
EP (2) EP2060586A1 (enExample)
JP (1) JP2011503137A (enExample)
CN (1) CN101878226B (enExample)
AU (1) AU2008323041A1 (enExample)
CA (1) CA2703894A1 (enExample)
DK (1) DK2212352T3 (enExample)
MX (1) MX2010005280A (enExample)
WO (1) WO2009062898A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
WO2014090905A1 (en) * 2012-12-11 2014-06-19 Imaxio Modified coiled coil type proteins having improved properties
JP2016520534A (ja) 2013-03-18 2016-07-14 イマクシオＩｍａｘｉｏ インフルエンザ核タンパク質ワクチン
US9850278B2 (en) 2013-04-25 2017-12-26 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
US12295990B2 (en) 2018-11-09 2025-05-13 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP2001504447A (ja) 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
CA2388910C (en) * 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013032375; ＢＥＲＫＥＬ，　Ｐ．Ｈ．Ｃ．，　ｅｔ　ａｌ．: Ｂｉｏｃｈｅｍ．　Ｊ． ３２８, 1997, ｐｐ．１４５-１５１ *

Also Published As

Publication number Publication date
DK2212352T3 (da) 2014-09-29
EP2212352A1 (en) 2010-08-04
CN101878226A (zh) 2010-11-03
US20090186823A1 (en) 2009-07-23
US8815812B2 (en) 2014-08-26
MX2010005280A (es) 2010-08-31
CA2703894A1 (en) 2009-05-22
EP2060586A1 (en) 2009-05-20
AU2008323041A1 (en) 2009-05-22
US7928185B2 (en) 2011-04-19
US20110224152A1 (en) 2011-09-15
WO2009062898A1 (en) 2009-05-22
CN101878226B (zh) 2014-06-25
EP2212352B1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
JP6158712B2 (ja) 新規合成ペプチド及びそれらの使用
JP2002519438A (ja) 人ラクトフェリンの配列に基づくペプチドおよびその使用
AU2012210564A1 (en) Human lactoferrin based peptides having antiinflammatory activity
AU2012210565A1 (en) Human lactoferrin derived peptides and there use
US8815812B2 (en) Synthetic arginine substituted peptides and their use
US20110053833A1 (en) Synthetic peptides and their use
HK1149769A (en) New synthetic arginine substituted peptides and their use
Ramos Recombinant expression and activity of cationic antimicrobial peptides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111109

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20121026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20121026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130702

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140107